National Health Investors Temettü

Temettü kriter kontrolleri 5/6

National Health Investors kazançlarla iyi bir şekilde karşılanan, 4.74% cari getiriye sahip, temettü ödeyen bir şirkettir.

Anahtar bilgiler

4.7%

Temettü verimi

0.01%

Geri Alım Getirisi

Toplam Hissedar Getirisi	4.8%
Gelecekteki Temettü Verimi	4.9%
Temettü Büyümesi	2.3%
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	US$3.600
Ödeme oranı	81%

Son temettü güncellemeleri

Recent updates

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

Feb 21

6%-Yielding National Health Investors: No Pain, No Gain

Feb 06

National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot

Sep 10

National Health Investors Q2 Earnings Preview

Aug 07

National Health Investors: A 5.8% Yield, And Little Else

Jun 29

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: NHI şirketinin temettü ödemeleri son 10 yıldır dalgalı seyretti.

Büyüyen Temettü: NHI şirketinin temettü ödemeleri son 10 yıldır artış göstermektedir.

Piyasaya Karşı Temettü Getirisi

National Health Investors Piyasaya Karşı Temettü Getirisi

NHI temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (NHI)	4.7%
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.5%
Sektör Ortalaması (Health Care REITs)	3.6%
Analist tahmini (NHI) (3 yıla kadar)	4.9%

Önemli Temettü: NHI 'in temettüsü ( 4.74% ), US piyasasındaki temettü ödeyenlerin en alttaki %25'inden ( 1.44% ) daha yüksektir.

Yüksek Temettü: NHI 'in temettüsü ( 4.74% ) US pazarındaki temettü ödeyenlerin en üst %25'indedir ( 4.51% )

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Mevcut ödeme oranı ( 81% ) ile NHI 'un ödemeleri kazançlarla karşılanmaktadır.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Mevcut nakit ödeme oranı ( 82.9% ) ile NHI 'un temettü ödemeleri nakit akışları tarafından karşılanmaktadır.

National Health Investors Temettü

Temettü kriter kontrolleri 5/6

Anahtar bilgiler

Son temettü güncellemeleri

Upcoming dividend of US$0.90 per share

National Health Investors, Inc. Announces Dividend for the Second Quarter of 2024, Payable on August 2, 2024

Upcoming dividend of US$0.90 per share

Upcoming dividend of US$0.90 per share at 6.3% yield

National Health Investors, Inc. Announces Its Fourth Quarter Dividend, Payable on January 26, 2024

Upcoming dividend of US$0.90 per share at 7.1% yield

Recent updates

National Health Investors, Inc. to Report Q3, 2024 Results on Nov 05, 2024

National Health Investors: From Struggles To Strength

Senior VP & Chief Transaction Officer exercised options and sold US$752k worth of stock

Upcoming dividend of US$0.90 per share

Executive VP of Finance exercised options and sold US$1.3m worth of stock

Executive VP & Chief Investment Officer exercised options and sold US$1.9m worth of stock

Price target increased by 12% to US$78.50

Independent Director exercised options to buy US$767k worth of stock.

New minor risk - Shareholder dilution

National Health Investors, Inc. has completed a Follow-on Equity Offering in the amount of $171 million.

National Health Investors, Inc. has filed a Follow-on Equity Offering.

Second quarter dividend of US$0.90 announced

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Provides Earnings Guidance for the Full Year 2024

Independent Director exercised options and sold US$656k worth of stock

National Health Investors, Inc. to Report Q2, 2024 Results on Aug 06, 2024

National Health Investors, Inc.(NYSE:NHI) dropped from Russell Small Cap Comp Growth Index

Land & Buildings Investment Management Comments on National Health Investors’ Supplemental Proxy Statement

First quarter dividend of US$0.90 announced

National Health Investors: The Lack Of Upside Seems Obvious To Me Here

National Health Investors, Inc. Announces Dividend for the Second Quarter of 2024, Payable on August 2, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting

National Health Investors, Inc. to Report Q1, 2024 Results on May 06, 2024

National Health Investors, Inc., Annual General Meeting, May 22, 2024

Upcoming dividend of US$0.90 per share

Price target increased by 7.2% to US$62.00

Insufficient new directors

Independent Director recently bought US$587k worth of stock

Price target increased by 7.5% to US$59.86

Fourth quarter dividend of US$0.90 announced

National Health: Lots To Love, But Valuation Still On The High Side

Full year 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Provides Earnings Guidance for the Year 2024

National Health Investors, Inc. to Report Q4, 2023 Results on Feb 20, 2024

Upcoming dividend of US$0.90 per share at 6.3% yield

Catch The Senior Housing Rebound With National Health Investors

National Health Investors: 7% Yielding REIT Has Improved On Most Metrics

National Health Investors, Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

National Health Investors, Inc. Announces Its Fourth Quarter Dividend, Payable on January 26, 2024

National Health Investors, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Upcoming dividend of US$0.90 per share at 7.1% yield

National Health Investors: Enjoy This Solid 7%+ Yield, For Now

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

National Health Investors, Inc. Announces Third Quarter 2023 Dividend, Payable on November 3, 2023

National Health Investors, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Upcoming dividend of US$0.90 per share at 6.8% yield

National Health: What We Got Wrong With This Healthcare REIT

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Announces Second Quarter 2023 Dividend, Payable on August 4, 2023

Full year 2022 earnings: EPS misses analyst expectations

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

6%-Yielding National Health Investors: No Pain, No Gain

National Health Investors, Inc. to Report Q4, 2022 Results on Feb 21, 2023

Upcoming dividend of US$0.90 per share

Independent Director recently bought US$57k worth of stock

National Health Investors, Inc. (NYSE:NHI) acquired Bickford of Virginia Beach from Bickford Senior Living, L.L.C. for $14 million.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Announces Fourth Quarter 2022 Dividend, Payable on January 27, 2023

Consensus EPS estimates fall by 21%

National Health Investors, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Upcoming dividend of US$0.90 per share

National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot

Chief Investment Officer exercised options and sold US$220k worth of stock

Price target increased to US$62.71

Independent Director recently bought US$99k worth of stock

Second quarter 2022 earnings: EPS and revenues miss analyst expectations